3-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{2-[2-(propan-2-yl)-1H-benzimidazol-1-yl]ethyl}propanamide
Chemical Structure Depiction of
3-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{2-[2-(propan-2-yl)-1H-benzimidazol-1-yl]ethyl}propanamide
3-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{2-[2-(propan-2-yl)-1H-benzimidazol-1-yl]ethyl}propanamide
Compound characteristics
Compound ID: | J101-0265 |
Compound Name: | 3-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-{2-[2-(propan-2-yl)-1H-benzimidazol-1-yl]ethyl}propanamide |
Molecular Weight: | 433.51 |
Molecular Formula: | C24 H27 N5 O3 |
Smiles: | CC(C)c1nc2ccccc2n1CCNC(CC[C@@H]1C(Nc2ccccc2C(N1)=O)=O)=O |
Stereo: | ABSOLUTE |
logP: | 3.0276 |
logD: | 3.0078 |
logSw: | -3.605 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 85.442 |
InChI Key: | VHQYZBCEFIKJEI-LJQANCHMSA-N |